{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to understand the drug utilization pattern of ticagrelor in patients with myocardial infarction (TARGET-MI)

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients with myocardial infarction do you come across in a month? *

  2. What percentage of myocardial infarction patients fall under each of below mentioned age categories? *
    3. Age categories % Patient
    <45 years
    %
    45-65 years
    %
    >65 years
    %
  3. What percentage of myocardial infarction patients are male and female? *
    4. Gender % Patient
    Male
    %
    Female
    %
  4. What is the body mass index (BMI) of most of the myocardial infarction patients you encounter in your practice? *

  5. What are the most common risk factors/ comorbidities you see in myocardial infarction patients? *
  6. How many myocardial infarction patients per week in your practice undergo percutaneous coronary intervention and what proportion of patients end up in heart failure? *
  7. Out of 100 acute coronary syndrome patients, what percentage of patients fall under each of the below categories? *
    8. Type of ACS patient % Patient
    STEMI
    %
    NSTEMI
    %
    Unstable Angina
    %
  8. What factors in your practice influences your decision on the reperfusion strategy? *
  9. Out of 100 acute coronary syndrome patients, what percentage of patients require either of the below approach? *
    10. Type of Treatment % Patient
    Primary percutaneous coronary intervention (PCI)
    %
    Thrombolytic therapy
    %
  10. In which of the acute coronary syndrome patients do you consider using thrombolytics therapy? *
  11. Currently how many % of myocardial infarction patients are on the following anti platelet agents? *
    12. Drug % Patient
    Aspirin
    %
    Clopidogrel
    %
    Ticagrelor
    %
    Prasugrel
    %
  12. In high risk of bleeding patient who has undergone PCI for ACS, which is the preferred antiplatelet agent? *

  13. Do you prescribe antiplatelet agent >12 months? *

  14. Therapy Duration wise, in what percentage of patients do you prescribe Ticagrelor *
    15. Duration % Patient
    > 3 months
    %
    > 6 months
    %
    > 9 months
    %
    > 12 months
    %
  15. What percentage of your patients receive the SAPT & DAPT? *
    16. Type of Therapy % Patient
    SAPT
    %
    DAPT
    %
  16. What is your most preferred antiplatelet agent for SAPT? *

  17. In your experience, which DAPT has shown the best outcomes in MI patients? *

  18. How long do you prescribe DAPT of (P2Y12+ASPIRIN)? *

  19. In which patient profiles you will prefer Ticagrelor over Clopidogrel? Why? *
  20. In which patient profile do you prescribe Ticagrelor 60 mg? *

  21. In what % of patients you switch/change the antiplatelet treatment? *

  22. In diabetes patients with established CAD who have undergone PCI before, will you reinitiate antiplatelet? *

  23. While Selecting Brand of Ticagrelor which parameters do you consider? *
  24. Are you aware of any ongoing clinical trials investigating novel molecules or therapies for MI? *

  25. What steps can be taken from patient point of view for the awareness and education about benefits and risks of antiplatelet agents? *